Earnings History Data for Evotec SE (EVO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Evotec SE
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | EVO | Evotec SE | 1,560 | N/A | -0.09 | 0.00 | Evotec SE reports nine-month results [11/6/2024 5:40 AM] |
3.85 | -0.73 (-16.05%) |
3.81 | -0.77 (-16.81%) |
2.85 - 12.00 | 118,806 | 210,000 | 28,677 | ||
|
||||||||||||||||||
| 14-08-2024 | PM | EVO | Evotec SE | 1,090 | N/A | -0.05 | 0.00 | Evotec SE reports 1H results [8/14/2024 10:07 AM] |
3.31 | -0.01 (-0.30%) |
3.29 | -0.03 (-0.89%) |
2.85 - 12.40 | 104,863 | 220,000 | 4,974 | ||
| 22-05-2024 | PM | EVO | Evotec SE | 1,860 | N/A | -0.06 | 0.00 | Evotec SE reports Q1 results; reaffirms FY24 outlook [5/22/2024 1:54 AM] |
5.14 | 0.05 (0.98%) |
5.04 | -0.05 (-0.98%) |
4.87 - 13.49 | 224,691 | 160,000 | 5,570 | ||
| 08-11-2023 | PM | EVO | Evotec SE | 3,140 | N/A | -0.03 | 0.00 | Evotec SE reports 9M results [11/8/2023 9:08 AM] |
9.27 | 0.57 (6.55%) |
9.31 | 0.61 (7.01%) |
7.80 - 13.49 | 42,461 | 30,000 | 7,899 | ||
| 29-08-2023 | PM | EVO | Evotec SE | 4,010 | N/A | 0.04 | 0.00 | Evotec SE reports 1H results; updates FY23 guidance [8/29/2023 3:27 AM] |
11.99 | 0.55 (4.81%) |
11.20 | -0.24 (-2.10%) |
7.80 - 13.49 | 91,438 | 30,000 | 1,167 | ||
| 09-11-2022 | PM | EVO | Evotec SE | 3,360 | N/A | 0.08 | 0.00 | Evotec SE reports 9M results; outlook for FY2022 unchanged and mid-term targets 2025 confirmed [11/9/2022 3:28 AM] |
8.65 | -0.88 (-9.23%) |
8.66 | -0.87 (-9.13%) |
7.83 - 25.29 | 133,747 | 40,000 | 20,912 | ||
| 11-08-2022 | PM | EVO | Evotec SE | 4,730 | N/A | -0.01 | 0.22 | Evotec SE reports 1H results; updates FY22 guidance and mid-term targets of 2025 confirmed [8/11/2022 2:03 AM] |
13.12 | -0.01 (-0.08%) |
12.95 | -0.18 (-1.37%) |
10.60 - 26.57 | 51,991 | 50,000 | 6,588 | ||